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Abstract 
Purpose: To evaluate the main reasons for returning intravenous (IV) medications and to determine its 
cost impact in an in-patient setting in a Saudi tertiary care hospital.  
Methods: The study was conducted over a one-month period at the central IV room of the in-patient 
pharmacy unit at King Abdulaziz Medical City (KAMC), Riyadh, Saudi Arabia. All returned IV 
medications were evaluated in terms of frequency, causes and cost.  
Results: The total number of IV medications returned was 2,061 items. The most common reasons for 
returning IV medications were drug discontinuation (933 items, 45.3 %), dispensing of an extra quantity 
(396 items, 19.2 %), patient deaths (173 items, 8.4 %), dose changes (171 items, 8.3 %) and drugs 
being held (150 items, 7.3 %). The total cost of all the returned IV medications was US$26,805.80), 
which accounts for (13.65 %) of the total pharmacy’s budget. Wasted medication cost was 
US$13,877.80) which constitute 51.77 % of returned medication cost.  
Conclusions: The results of this study indicate that IV medication wastage is a serious problem with 
significant cost impact, with drug discontinuation and dispensing of an extra quantity of medication 
being the two main reasons for returning IV medications. Effective communication among health care 
professionals, pharmacist training, and adherence to standard practice guidelines might be the most 
vital strategies to reduce medication wastage.  
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Medications wastage is a major issue facing all 
health care systems worldwide. It imposes a 
significant financial burden on the pharmacy’s 
budget, not only because of the cost of items 
being returned but also due to the wasted time 
and the cost of disposing of wasted medications 
[1]. Medications wastage contributes a large 
proportion of the ballooning health care cost 
worldwide. In the United States, for example, the 
estimated cost of wasted medications is more 
than $ 1 billion yearly [2,3]. The financial value of 
medications that are not used or wasted in the 
United Kingdom is estimated to reach up to £ 
300 million annually [4]. In Canada, medications 
wastage has been cited as one of the most 
critical factors for the increasing consumption of 
AlSamanhodi et al 
Trop J Pharm Res, January 2017; 16(1): 232  
 
pharmaceutical products and rising health care 
cost, which has been estimated to be 
approximately $ 8 billion per year [5]. 
 
Practically, medications wastage cannot be 
completely eliminated. However, carefully 
examining contributing factors and identifying the 
most common and expensive medications 
involved, is certainly worthwhile, and may help in 
recognizing the most suitable measures to 
reduce medication wastage [6]. 
 
Many studies have been conducted to address 
medications wastage issue [3,4,6-13]. However, 
the majority of these studies were carried out in 
outpatient setting [3,4,6,7,9-11,13]. Not much is 
documented on investigating the causes and 
cost impact of medications wastage in the 
inpatient setting [8,12]. Similarly,  in Saudi 
Arabia, few studies on medication wastage have 
been conducted in the outpatient setting [14] and 
only one study in inpatient setting [8]. This study 
was conducted at a tertiary university teaching 
hospital in Riyadh. The data were collected in the 
inpatient pharmacy over a period of one month. 
One thousand two hundred and eighteen 
medications were dispensed, out of which 265 
(21.75 %) medications were returned to the 
inpatient pharmacy. The major reasons for 
returning the medications were: medication 
discontinuation, switching from IV therapy to 
oral, patient discharge, extra dose delivery, refill 
order and patient death. The total cost of wasted 
IV medications was estimated to be around 
28,800 SAR per month ($ 7679.1) [8]. 
 
The aims of this study were to investigate the 
main reasons for returning IV medications and to 
calculate its cost impact in an inpatient setting. 
The findings will be used to help developing 




Study design and setting 
 
The study was a cross-sectional, observational 
study performed over a period of one month at 
the central IV room of the inpatient pharmacy at 
King Abdulaziz Medical City (KAMC). KAMC is a 
1025 bed tertiary care hospital in Riyadh, Saudi 
Arabia.  
 
The inpatient pharmacy is a part of the 
pharmaceutical care services department at 
KAMC. It provides 24 hours services covering all 
admitted patients. During the day shift, 
pharmaceutical services are provided through a 
decentralized system (satellite pharmacies) and 
during the evening and night shifts through 
centralized pharmacy system with limited satellite 
pharmacy services. 
 
The study was approved by the Institutional 
Review Board (IRB) of King Abdullah 
International Medical Research Center 




During the study period and on a daily basis, the 
returned IV medications were collected in the IV 
room fridge. Data collection sheet was developed 
to collect all pertinent information including: 
medication name, dose, quantity, type of IV 
preparation (IV piggyback, IV syringes or IV large 
volume), reason for returning, recycling status, 
therapeutic/pharmacological classification, and 
unit cost of the medication. 
 
Depending on the stability of the IV preparation 
and whether or not the returned amount can be 
used again, the returned items were categorized 
into recyclable and non-recyclable preparations. 
All returned non-recyclable items were defined 
as “wastage”. The reasons for returning the IV 
preparations were obtained by using the 
pharmacy computer system and through 
contacting the responsible nurse/pharmacist 
when necessary.  
 
The total cost of all the returned items was 
calculated using the unit prices provided by the 
Logistics and Contracts Management 




Data were extracted from data collection sheets 
and entered into Microsoft Excel® (2010). All of 
the data in this study were categorical and were 




Frequency and cost of returned medications 
 
During the study period, a total of 2,061 items 
were returned to the main pharmacy. Details for 
returned medications were complete for 1,965 
(95.34 %) items. Of these, 627 items (30.42 %) 
were recyclable while 1,434 items (69.57 %) 
were non-recyclable and therefore wasted. The 
total cost of returned medications during the 
study period was US$26,805.80). This amount 
accounted for 13.65 % of the pharmacy 
department’s budget for the IV room at the 
hospital. Of this amount, non-recyclable items 
worth US$13,877.80) and constitute 51.77 % of 
returned medications cost.  
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The frequencies of returned medications for 
adults and paediatrics sections are summarized 
in Table 1. Most of the returned medications 
were from the adults’ section (70.6 %).  
 
Table 1: Distribution frequency of returned 























The unit with the most frequently returned items 
in the paedatrics’ section was the paediatric 
cardiac intensive care unit (229 items, 11.11 %), 
followed by the general paediatric intensive care 
unit (106 items, 5.14 %).  The unit with the most 
frequently returned items in the adults’ section 
was the medical intensive care unit (95 items, 4.6 
%).  
 
Most frequently returned medications 
 
The most frequently returned classes of 
medications with their respective cost are 
summarized in Table 2. The most frequent class 
of returned IV medications was antibiotics with 
971 items (47.11 %)  and  had a financial value 
of 28.38 % of the total returned  items cost, while 
electrolyte replacement preparations were the 
second most frequent  (356 items,17.27 %) and 
had a financial value of 2.24 % of the total cost. 
Gastrointestinal drugs were the third most 
frequent (135 items, 6.55 %) and accounted for 
2.38 % of the total cost. Analgesics and 
antipyretics were the fourth most frequent (107 
items, 5.19 %) with a financial value of 0.75 % of 
the total cost. Blood derivatives were the fifth 
most frequent with (93 returned items, 4.51 %) 
and accounted for 16.83 % of the total cost. 
 
The most frequently returned specific 
medications with their respective cost are 
summarized in Tables 3. Potassium chloride was 
the most frequently returned medication. Three 
of the top five returned medications were 
antibiotics.  
 
Reasons for returning medications 
 
Figure 1 illustrates the most common reasons for 
returning IV medications. The most common 
reasons for returning IV medications were 
medication discontinuation (933 items, 45.30 %), 
dispensing of an extra quantity (396 items, 19.20 
%), patient deaths (173 items, 8.4 %), dose 
changes (171 items, 8.3 %) and medication 
being held (150 items, 7.3 %). In the majority of 
classes, items were most frequently returned as 
a result of medication discontinuation except for 
analgesics and antipyretics which had the 
highest return rate due to dispensing of an extra 




The results of this study indicated that antibiotics 
are the most frequently returned class of 
medications. This finding is consistent with other 
published studies [8,12]. Gastrointestinal drugs, 
electrolyte replacement preparations, analgesics, 
and antipyretics were also among the top five 
classes of returned medications. The units with 
the most returned items were the paediatric 
intensive care unit and the adult medical 
intensive care unit where these medications are 
frequently used. To reduce wastage; therefore, 
rational drug use should be emphasized in these 
units.  
 
The most common reason for returning 
intravenous medications was discontinuation of 
medications per physician order. Similar findings 
were reported in previous studies [8]. One of the 
main factors that may explain this finding is the 
lack of adherence to international guidelines 
regarding the use of medications, antibiotics in 
particular. According to a recent study, nearly a 
third of antibiotics prescribed in the United States 
are unnecessary [15]. 
 
Physicians tend to prescribe expensive potent IV 
antibiotics for clinical conditions that do not 
require them, refuse to switch to the much 
cheaper oral alternatives per guideline 
recommendations, and misdiagnose viral 
infections as bacterial causes resulting in the 
indiscriminate use of antibiotics. In the majority of 
cases, antibiotics were initiated, then 
discontinued upon negative results of septic 
workup and clinical improvement of patients. 
 
Dispensing of an extra quantity of medications 
was the second most common reason for IV 
medications being returned to the main 
pharmacy. This can be remedied by training and 
directing staff pharmacists to be extra vigilant 
through meticulous checking to ensure that the 
appropriate amount of prescribed medication is 
dispensed.  
 
Medications dose changes were also a common 
reason for intravenous medications being 
returned to the main pharmacy. Very little, if 
anything, can be done to change the need for  
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         Note: Exchange rate of SAR3.75 to US$1.00 used for converting costs in Saudi riyal to US dollar 
 
         Table 3: Top five returned medications and their respective cost 
 
Medication  Frequency Cost (US$) 
Potassium chloride 170 (8.25%) 32.80 (0.12%) 
Vancomycin 161 (7.81%) 870.96 (3.25%) 
Metronidazole 127 (6.16%) 71.12 (0.26%) 
Tazocin 115 (5.58%) 1035.0 (3.86%) 
Acetaminophen 107 (5.19%) 199.73 (0.75%) 
Note: Exchange rate of SAR3.75 to US$1.00 used for converting costs in Saudi riyal to US dollar 
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Figure 1: Reasons for returning IV medications 
 
medication dosage adjustments when necessary 
because of either hepatic or renal impairment.  
 
The best way to reduce intravenous medications 
being returned to the main pharmacy, as a result 
of medications being held and never resumed, 
would be for staff pharmacists to ensure that the 
unit-dose drug distribution system is strictly 
adhered to. Using this approach, only a small 
quantity would be wasted, if a medication is held 
and never resumed. The use of unit-dose drug 
distribution system has also been found to 
reduce medication errors substantially [16]. 
 
Early discharge of patients was also a common 
reason for returning IV medications.   
Encouraging physicians to plan the discharge of 
their patients about two to three days ahead of 
time and switching to oral medications as soon 
as feasible would be helpful in reducing wastage 
of medications. The discharge planning process, 
when conducted early, has been shown to 
improve patients’ care and the cost-effective use 
of resources [17].  
 
It was evident from the results that more than 
half of the returned medications were wasted 
because of non-recyclability. Inability to recycle 
has been found to be the result of two major 
factors namely, short stability of IV preparations 
and using unstandardized doses. Implementing 
dosing standardization and polices that guide the 
medication use process in the hospital setting 
have also been found to be important in 
minimizing medication errors and promoting 
medication safety and control [18]. 
 
The study results indicate clearly that the current 
strategies in dealing with IV medications are not 
effective in reducing the wastage of medications 
and therefore there is an urgent need to 
implement new strategies. Lack of effective 
communication among different health care 
providers who are involved in the medication use 
process plays a major role and should be the 
focus of these strategies. Improving 
communication among health care providers will 
lead to vast improvement in health care including 
reducing the amount of returned IV medications 
and consequently, reduce the wastage and 
render the pharmacy staff more productive [19]. 
 
A recent study has also evaluated the impact of 
increasing the use of premixed IV solutions and 
increased IV production frequency on IV 
wastages [20]. Using these strategies, the 
number of wasted IV doses has been reduced 
from 2673 (6.14 %) to 675 (1.69 %) per month.  
 
Finally, it should be noted that the total cost of 
the returned intravenous medications quoted in 
this study is the cost of the wasted medications 
alone. Thus, if other ancillary costs such as cost 
of wasted bottles or piggybacks, large volume 
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bags, wasted efforts and time of pharmacists and 
pharmacy technicians are considered, the 
cumulative cost would certainly be enormous. 
 
Limitations of the study 
 
There are several limitations to this study. These 
limitations include: short duration, single center, 
not including the ancillary cost of the 
medications, and the lack of a structured 





IV medications wastage is a serious problem in 
the inpatient setting and has a significant cost 
impact. This study has highlighted that drug 
discontinuation and dispensing of an extra 
quantity of medications were the two main 
reasons for returning IV medications. Current 
strategies in dealing with returned IV medications 
are not effective in reducing the wastage of 
medications and therefore there is an urgent 
need to implement new strategies. Effective 
communication between health care 
professionals, pharmacists training, and 
adherence to standard practice guidelines 
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